OPT
OPT, Inc. is Japanese e-marketing company, which supports customer's Internet marketing holding the concept 'e-marketing that would directly into sales'. OPT, Inc. aims to create new market by realizing maximizing customer's ROI and finding the best way of solutions to the customer's problem. It is the OPT's task to propose collectively the way how to use the Internet as a marketing tool for customers and support them. In order to maximize customer's ROI, it is necessary to make ads, ... develop sites, develop marketing strategies, and support communication and IT strategies.At OPT. Inc: it has wide business lines, customers would be supported by the 4 business fields making ads, technology, solution, and contents. The important thing for the e-marketing company is always standing the idea "market in" not "product out". And so OPT, Inc instantaneously developed its own tool to objectively effect measurement and has tried to improve customer's marketing by using the objective data.
OPT
Industry:
Advertising Advertising Platforms Digital Marketing E-Commerce Information Technology Marketing
Founded:
1994-03-04
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.opt.ne.jp
Total Employee:
1001+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
GrowthFalcons
Achieve Rapid & Sustainable Business Growth With 360 Degree Growth Hacking.
Huge Ape Media
Internet Marketing and Technology
WhyteSpyder
WhyteSpyder is an integrated marketing agency that focuses on one-to-one relationship marketing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-03-19 | Crossfinity Digital Asia | Crossfinity Digital Asia acquired by OPT | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-01 | OPT China | OPT investment in Corporate Round - OPT China | 220 M JPY |
| 2016-09-26 | Shuttlerock | OPT investment in Series B - Shuttlerock | 2.5 M NZD |
| 2016-08-03 | Raksul | OPT investment in Series D - Raksul | 20.2 M USD |
| 2015-03-11 | MarketEnterprise | OPT investment in Corporate Round - MarketEnterprise | 204 M JPY |
| 2015-02-27 | Fuller | OPT investment in Venture Round - Fuller | 1.9 M USD |
| 2015-02-17 | Raksul | OPT investment in Series C - Raksul | 33.7 M USD |
| 2015-02-13 | lancers | OPT investment in Corporate Round - lancers | 18 M JPY |
| 2014-11-11 | Nota | OPT investment in Series A - Nota | 2 M USD |
| 2014-09-01 | Omni | OPT investment in Seed Round - Omni | 3 M USD |
| 2014-07-07 | Cocon | OPT investment in Seed Round - Cocon | 1.37 M USD |
Official Site Inspections
http://www.opt.ne.jp
- Host name: server-3-167-56-43.iad61.r.cloudfront.net
- IP address: 3.167.56.43
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "OPT"
OPT - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +81 357453611 OPT is a Japanese e-marketing company, that supports customer Internet marketing, holding the concept of e-marketing that …See details»
Novocure | cancer therapy: Tumor Treating Fields (TTFields)
4 days ago On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Patient images …See details»
Optune (NovoTTF-200A) - NCBI Bookshelf - National …
The Optune system consists of an electric field generator, a connection cable and box, transducer arrays, a shoulder bag and strap, 4 portable batteries, a charger for portable batteries, a plug-in power supply, and power cords . 28-30 The …See details»
Alternating electric field therapy - Wikipedia
All living cells contain polar molecules and will respond to changes in electric fields. Alternating electric field therapy, or Tumor Treating Fields (TTFields) use insulated electrodes to apply very-low-intensity, intermediate-frequency alternating electrical fields to a target area containing cancerous cells. Polar molecules play a key role in cell division, making mitosis particularly susceptibl…See details»
FDA approves Novocure’s tumor field therapy for …
Oct 16, 2024 Novocure submitted Optune Lua for FDA review in NSCLC in December 2023, after also seeking a CE Mark approval in Europe. Around the same time—and following the field’s failure in a phase 3 ...See details»
Optune (NovoTTF-200A) | Canadian Journal of Health Technologies
Mar 19, 2024 Optune en combinaison avec le témozolomide n’est pas considéré comme rentable comparativement au témozolomide seul aux seuils de disposition à payer habituels …See details»
The Optune device is also being tested as a treatment …
Nov 22, 2016 Optune uses a frequency of 200 kHz, which gets inside glioblastoma cells but doesn’t penetrate neurons and other normal brain cells. It doesn’t hurt that there’s very little cell division ...See details»
Shiseido Launches Full-Scale IoT*1 Skincare Service …
Jul 1, 2019 The variety of solutions the new Optune provides is also reinforced and enabled with new analysis of external factors including pollen and PM2.5. Furthermore, Optune can sense the users’ sleep condition and provide a one …See details»
Tumour treating fields in a combinational therapeutic approach
Nov 11, 2018 Optune in combination with Temozolomide (TMZ) has been approved for use in adult patients with newly diagnosed GBM following maximal safe resection, as well as …See details»
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT …
ROOT, Switzerland, January 09, 2024--Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the global phase 3 TRIDENT clinical trial evaluating the …See details»
Editor's choice: The cost-effectiveness of tumor-treating fields ...
May 13, 2016 For TTF therapy, we considered the utilization of Optune (Novocure Inc.). To date, there is no regulated tariff for this medical device, but the cost reported by the company is €21 …See details»
Tumour Treating Fields (TTF) or Optune® - The Brain Tumour …
Tumour Treating Fields (TTF) or Optune® for brain tumours Tumour treating fields, also known as TTF or TT Fields, is a relatively new, non-invasive technique for adults with a type of brain …See details»
Tumor Treating Fields for Glioblastoma Treatment: Patient …
Jan 29, 2019 Tumor treating fields (TTFields) are a non-invasive antimitotic therapy that delivers alternating electric fields via the Optune ® system. The Phase III EF-14 trial in newly …See details»
Optune: Uses, Side Effects, Dosages, Precautions - Verywell Health
Jan 20, 2023 Optune is a newer treatment approach for taking on glioblastoma (GBM), the most common form of brain cancer. Optune is a device that delivers low-intensity electrical fields to …See details»
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide …
Patients eligible for this study were aged 18 years or older, had a Karnofsky performance score of 70 or higher (a score of ≥70 ensures independence in activities of daily living), and had newly …See details»
Optune (NovoTTF-200A) - canjhealthtechnol.ca
The Optune system consists of an electric field generator, a connection cable and box, transducer arrays, a shoulder bag and strap, 4 portable batteries, a charger for portable batteries, a plug …See details»
FDA Approves Novocure’s Optune Lua® for the Treatment of …
Oct 15, 2024 The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic …See details»
Maintenance Therapy With Tumor-Treating Fields Plus …
Patients receiving TTFields had 4 transducer arrays placed on the shaved scalp and connected to a portable device set to generate 200-kHz electric fields within the brain (Optune, Novocure …See details»
Alternating Electric Fields ("Tumour- Treating Fields") for the ...
Optune is intended for treatment of glioblastoma in the supratentorial (or upper) ... Knisely JP. Tumor-treating fields-a fundamental change in locoregional management for glioblastoma. ...See details»
PhRMA Wants No Off-Year Price Cuts, Urges Japan Not to …
Nov 19, 2024 ORGANIZATION. DPP Head, Industry Leaders United towards Stopping Off-Year Price Revisions. November 29, 2024. PhRMA Wants No Off-Year Price Cuts, Urges Japan …See details»